# Disrupted bone microenvironment and immune recovery following total body irradiation in a murine model

**Authors:** Tibor Sághy, Priti Gupta, Karin Horkeby, Petra Henning, Claes Ohlsson, Carmen Corciulo, Marie K. Lagerquist, Andrei S. Chagin, Cecilia Engdahl

PMC · DOI: 10.1038/s41419-025-08303-7 · Cell Death & Disease · 2025-12-13

## TL;DR

This study shows that total body irradiation disrupts bone and immune function in mice, with long-term effects on bone marrow and skeletal health.

## Contribution

The study reveals a link between persistent apoptotic cells and impaired bone remodeling after irradiation and HSCT.

## Key findings

- Irradiation caused bone loss and increased bone marrow cellularity 12 weeks post-treatment.
- Apoptotic cells and elevated Bax and TGF-β1 levels were observed in bone marrow for up to 12 weeks.
- Macrophages and pre-osteoclasts, but not mature osteoclasts, cleared apoptotic cells and released TGF-β1.

## Abstract

Irradiation is an effective therapy for eliminating cancer cells and serves as a critical preparative regimen for hematopoietic stem cell transplantation (HSCT). However, irradiation affects healthy tissue, disrupting bone tissue and bone marrow homeostasis, which leads to skeletal and immune dysfunction. To investigate these effects, we used a female murine model to explore the mechanisms underlying the skeletal damage caused by total body irradiation. Experiments were carried out over a 12-week period of total body irradiation and HSCT, supplemented by an acute study involving only total body irradiation and osteoclastogenesis. Irradiation resulted in a depletion of bone marrow immune cells, followed by an increase in bone marrow cellularity 12 weeks after irradiation and HSCT compared to naive controls, indicating late-stage local immune induction. Cortical and trabecular bone loss appeared 2 weeks post-irradiation and HSCT and persisted throughout the study. This bone damage was accompanied by a sustained increase in apoptotic cells in the bone marrow within 6 h post-irradiation and persisted for up to 12 weeks after irradiation and HSCT. This was coupled with elevated local expression of the pro-apoptotic Bax gene and an increase in TGF-β1, a gene associated with the clearance of apoptotic cells. In vitro studies demonstrated that macrophages and pre-osteoclasts, but not fully differentiated osteoclasts, efficiently cleared apoptotic cells, resulting in increased levels of TGF-β1 in the culture supernatant. While the clearance of apoptotic cells and associated TGF-β1 signaling were evident, their direct role in skeletal outcomes remains unclear. These findings suggest that persistent apoptotic cells contribute to impaired bone remodeling, potentially affecting osteoclast function and the bone microenvironment. Additional research is needed to investigate whether targeting apoptotic cell clearance can mitigate bone damage and promote skeletal recovery following irradiation.

## Linked entities

- **Genes:** BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040]

## Full-text entities

- **Genes:** Bax (BCL2-associated X protein) [NCBI Gene 12028], Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}
- **Diseases:** immune dysfunction (MESH:D007154), bone damage (MESH:D001847), cancer (MESH:D009369), skeletal damage (MESH:C535850)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12847818/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12847818/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12847818/full.md

---
Source: https://tomesphere.com/paper/PMC12847818